These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2823313)

  • 1. Delayed-onset synergism between leukotriene B4 and prostaglandin E2 in human skin.
    Archer CB; Page CP; Juhlin L; Morley J; MacDonald DM
    Prostaglandins; 1987 Jun; 33(6):799-805. PubMed ID: 2823313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4.
    Camp RD; Coutts AA; Greaves MW; Kay AB; Walport MJ
    Br J Pharmacol; 1983 Nov; 80(3):497-502. PubMed ID: 6315118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiating effects of leukotriene B4 and prostaglandin E2 on urinary sodium excretion by the dog kidney.
    Hébert RL; Lamoureux C; Sirois P; Braquet P; Plante GE
    Prostaglandins Leukot Med; 1985 Apr; 18(1):69-80. PubMed ID: 2987978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man.
    McGivern DV; Basran GS
    Eur J Pharmacol; 1984 Jun; 102(1):183-5. PubMed ID: 6592097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin.
    Soter NA; Lewis RA; Corey EJ; Austen KF
    J Invest Dermatol; 1983 Feb; 80(2):115-9. PubMed ID: 6296237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of synthetic leukotrienes on local blood flow and vascular permeability in porcine skin.
    Chan CC; Ford-Hutchinson A
    J Invest Dermatol; 1985 Feb; 84(2):154-7. PubMed ID: 2981933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue differences in vascular permeability induced by leukotriene B4 and prostaglandin E2 in the rat.
    Stenson WF; Chang K; Williamson JR
    Prostaglandins; 1986 Jul; 32(1):5-17. PubMed ID: 3020620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.
    Movat HZ; Rettl C; Burrowes CE; Johnston MG
    Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pruritogenic activity of prostaglandin E2.
    Hägermark O; Strandberg K
    Acta Derm Venereol; 1977; 57(1):37-43. PubMed ID: 74166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid.
    Aked DM; Foster SJ
    Br J Pharmacol; 1987 Nov; 92(3):545-52. PubMed ID: 2827824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeicosatetraenoic acid and its prevention by prostaglandin E2.
    Ruzicka T; Burg G
    J Invest Dermatol; 1987 Feb; 88(2):120-3. PubMed ID: 3027188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged microvascular vasodilation induced by leukotriene B4 in human skin is cyclooxygenase independent.
    Larkin SW; Fraser L; Showell HJ; Williams TJ; Warren JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):392-8. PubMed ID: 7815355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene B4: a mediator of vascular permeability.
    Bray MA; Cunningham FM; Ford-Hutchinson AW; Smith MJ
    Br J Pharmacol; 1981 Mar; 72(3):483-6. PubMed ID: 6266567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.
    Ruzicka T; Simmet T; Peskar BA; Ring J
    J Invest Dermatol; 1986 Feb; 86(2):105-8. PubMed ID: 3018086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE.
    Ferreri NR; Howland WC; Spiegelberg HL
    J Immunol; 1986 Jun; 136(11):4188-93. PubMed ID: 3009617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin.
    Archer CB; Page CP; Paul W; Morley J; MacDonald DM
    Br J Dermatol; 1984 Jan; 110(1):45-50. PubMed ID: 6581831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits the LTB4-induced skin response.
    Ternowitz T; Andersen PH; Bjerring P; Fogh K; Schröder JM; Kragballe K
    Arch Dermatol Res; 1989; 281(6):401-5. PubMed ID: 2556975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of itch and flare responses in human skin by prostaglandins E2 and H2 and a prostaglandin endoperoxide analog.
    Hägermark O; Strandberg K; Hamberg M
    J Invest Dermatol; 1977 Dec; 69(6):527-30. PubMed ID: 925375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questionable role of leukotriene B4 in monosodium urate (MSU)-induced synovitis in the dog.
    Carlson RP; Chang J; Datko LJ; Lewis AJ
    Prostaglandins; 1986 Oct; 32(4):579-85. PubMed ID: 3025938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of prostaglandin E2 and leukotriene B4 in skin reaction induced by transdermal application of propranolol.
    Kobayashi I; Hosaka K; Maruo H; Saeki Y; Kamiyama M; Konno C; Gemba M
    Biol Pharm Bull; 2000 Feb; 23(2):208-12. PubMed ID: 10706386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.